December 17th, 2010
Podcast 111: A look back on the year’s most clinically important developments.
Dr. Danielle Scheurer and Joe Elia have a free-form discussion on what’s happened over the past year. Links to those stories (and, sometimes, interviews) are attached here. If you’d like to suggest another, or comment on our selection, drop us a note in the comments field. Discussion-related links (they are all free links): Rivaroxaban Dabigatran Screening for lung cancer […]
December 3rd, 2010
Podcast 110: ARBs (and anti-hypertensives, generally) pose no measurable cancer risk, meta-analysis shows.
This week’s guest, Dr. Sripal Bangalore, finds no evidence that use of the standard anti-hypertensive drugs increases risks for cancer. His meta-analysis did find, however, an indication that ARBs and ACE inhibitors, when used in combination, increase risks modestly. Even with the short follow-up, Bangalore says clinicians should find reassurance in the results. Listen in. Interview-related links: Physician’s […]
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
